Effect of scopolamine and nootropic drugs on rewarded alternation in a T-maze
- PMID: 1475299
- DOI: 10.1016/0091-3057(92)90497-4
Effect of scopolamine and nootropic drugs on rewarded alternation in a T-maze
Abstract
The effects of different doses of scopolamine, and of the nootropic drugs oxiracetam and aniracetam, were investigated on the performance of male Wistar rats in a T-maze requiring a spatial discrimination in the stem (reference memory) and an alternate discrimination in the arms (working memory). Criterion (90% correct responses) was reached within 3 days of daily training for stem and 9 days for arm discrimination. Scopolamine (0.1, 0.2, 0.6, and 1.0 mg/kg, SC, 60 min before session) significantly impaired working memory, as shown by a decrease in the number of correct alternations, without affecting reference memory. Both nootropic drugs (25-50 and 100 mg/kg PO) 30 min before scopolamine) attenuated the working memory impairment induced by scopolamine.
Similar articles
-
Effect of oxiracetam on scopolamine-induced amnesia in the rat in a spatial learning task.Pharmacol Biochem Behav. 1992 Nov;43(3):949-51. doi: 10.1016/0091-3057(92)90430-n. Pharmacol Biochem Behav. 1992. PMID: 1448491
-
Differential effects of scopolamine and mecamylamine on working and reference memory in the rat.Pharmacol Biochem Behav. 1993 Jul;45(3):533-8. doi: 10.1016/0091-3057(93)90502-k. Pharmacol Biochem Behav. 1993. PMID: 8332613
-
Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze.Psychopharmacology (Berl). 1992;106(2):175-8. doi: 10.1007/BF02801969. Psychopharmacology (Berl). 1992. PMID: 1549645
-
Nootropic drugs and brain cholinergic mechanisms.Prog Neuropsychopharmacol Biol Psychiatry. 1989;13 Suppl:S77-88. doi: 10.1016/0278-5846(89)90112-7. Prog Neuropsychopharmacol Biol Psychiatry. 1989. PMID: 2694231 Review.
-
Assessment of the effects of drugs on memory.Psychopharmacol Ser. 1988;6:67-78. doi: 10.1007/978-3-642-73288-1_5. Psychopharmacol Ser. 1988. PMID: 3064087 Review.
Cited by
-
Aniracetam. An overview of its pharmacodynamic and pharmacokinetic properties, and a review of its therapeutic potential in senile cognitive disorders.Drugs Aging. 1994 Mar;4(3):257-73. doi: 10.2165/00002512-199404030-00007. Drugs Aging. 1994. PMID: 8199398 Review.
-
M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity.J Neurosci. 2004 Nov 10;24(45):10117-27. doi: 10.1523/JNEUROSCI.3581-04.2004. J Neurosci. 2004. PMID: 15537882 Free PMC article.
-
Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data.Psychopharmacology (Berl). 2005 Apr;179(1):154-63. doi: 10.1007/s00213-004-2065-6. Epub 2005 Jan 26. Psychopharmacology (Berl). 2005. PMID: 15672275 Review.
-
Scopolamine disrupts place navigation in rats and humans: a translational validation of the Hidden Goal Task in the Morris water maze and a real maze for humans.Psychopharmacology (Berl). 2017 Feb;234(4):535-547. doi: 10.1007/s00213-016-4488-2. Epub 2016 Nov 24. Psychopharmacology (Berl). 2017. PMID: 27885411 Clinical Trial.
-
Cholinergic modulation of the hippocampal region and memory function.J Neurochem. 2017 Aug;142 Suppl 2(Suppl 2):111-121. doi: 10.1111/jnc.14052. J Neurochem. 2017. PMID: 28791706 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources